A new study published in the journal Pharmacological Reports highlights the therapeutic potential of four newly developed fluorinated cannabinoids.
Conducted by researchers from Oklahoma State University Center for Health Sciences and Universität Regensburg in Germany, the study explores the biological activity of these compounds, particularly their anti-inflammatory properties.
“Phytochemicals derived from the plant Cannabis sativa hold promise in terms of medicinal value”, states the study. “Cannabinoids such as Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN) are arguably the best characterized and known to possess wide-ranging therapeutic benefits. The mechanism of action for these therapeutic effects remains to be fully elucidated, however, the anti-inflammatory actions are of particular interest.”
Researchers say that “Maximizing therapeutic effects while limiting adverse effects is crucial in pharmaceutical development. Fluorination of natural products often yields molecules with enhanced biological properties and provides opportunities for intellectual property protection not available to the natural product.”
For the study, researchers examined a trifluorinated cannabinol analog (F3CBN), a trifluorinated tetrahydrocannabinol analog (F3THC), and two pyridine-based compounds (SG126 and SG154). These fluorinated compounds were assessed for their effects on metabolic activity and cytokine expression in human C20 microglial cells, using established assays.
Findings revealed that F3CBN and F3THC enhanced interleukin-1β-induced expression of CXCL10 and IL-6, both linked to immune responses. Conversely, SG126 and SG154 inhibited these cytokine expressions, suggesting a potential for anti-inflammatory applications. Importantly, all four cannabinoids showed minimal impact on cellular metabolic activity at concentrations up to 10 µM, indicating a favorable safety profile for further exploration.
“These findings are foundational for new lines of investigation into the therapeutic potential of four novel fluorinated cannabinoids”, claim the study’s researchers.
For more information on this study, click here.
More articles from The Marijuana Herald:
